• Start
  • News
  • Studio
  • Events
  • Analyses
  • Newsletter
  • About BioStock
    • Contact us
    • Career
  • Swedish
Search
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
BioStock - Aktieanalyser & nyheter BioStock
BioStock - Aktieanalyser & nyheter
  • Start
  • News
  • Studio
  • Events
  • Analyses
  • Newsletter
  • About BioStock
    • Contact us
    • Career
  • Swedish
Home Nyheter BioStock launches International Newsletter
  • Nyheter
  • Recommended

BioStock launches International Newsletter

2 December, 2019

BioStock launches International Newsletter

2 December, 2019

The new BioStock international newsletter features a monthly overview of current sector news from the Nordics, including in-depth article series, interviews with executives, entrepreneurs and investors as well as coverage from major industry conferences and events, and much more.

BioStock is the Nordic region’s leading digital news and analytics service, focusing exclusively on the life science sector. Our news briefings, original articles and video content reach a broad audience through our multi-channel media platform and extensive media partner network. BioStock’s news updates are closely monitored by a majority of life science executives in the Nordic region, including high-profile investors as well as retail investors.

Expanding international reach

As competition for funding and partnerships is fierce, more life science companies are looking internationally for financial backing. BioStock initiated coverage of Swedish life science companies in 2015. During the last few years, the market interest for BioStock’s news, articles and interviews has grown exponentially. The same goes for both the Swedish and Nordic life science arenas. These factors combined have resulted in BioStock aiming to reach an even broader international audience.
For this purpose, BioStock has initiated an international expansion offering a wider range of content in English. The natural next step on this journey was the launch of the BioStock International Newsletter.

Check out the premiere edition of the BioStock International Newsletter here.

We hope and believe this newsletter will prove to be a useful source of information for both international investors, who see strong potential in the Nordic life science industry, and those with an interest in monitoring what the Nordic countries have to offer in terms of scientific breakthroughs and innovation.


Subscribe to the BioStock International Newsletter here!




Keeping track of what Nordic life science has to offer

With BioStock’s monthly international newsletter, our focus remains on the life science industry within the Nordic countries, covering the latest business deals as well as the latest research and medical breakthroughs and ongoing clinical trial developments within pharma, biotech and medtech. The newsletter also features BioStock’s latest article series, covering topics related to life science with the aim of providing a comprehensive view of major and current themes within the sector.

Dela gärna!

  • Facebook
  • Twitter
  • LinkedIn
  • Print
  • Email
  • TAGS
  • BioStock
  • International
  • International Newsletter
  • Life Science News
  • Newsletter
  • Nordic Life Science
  • Nordic Region
Previous articleA market gap and innovative treatment concept raise interest in new anti-thrombotic drugs
Next articleFluicell at the forefront of 3D bioprinting
Michael Jewett

RELATED ARTICLESMORE FROM AUTHOR

Elicera strong financial

Elicera Therapeutics strengthens financial standing in Q2

Så ska Stockholm bli världsledande inom Life Science

How Stockholm will become a world leading hub for Life Science

Cereno Scientific expands IPR protection to Japan

THE BIOSTOCK NEWSLETTER

The latest insights straight to your inbox

"*" indicates required fields

* Required fields
This field is for validation purposes and should be left unchanged.

biostock_news BioStock News @biostock_news ·
23 Jan

Ultimovacs Announces Completed Patient Recruitment in NIPU Phase II Clinical Trial of UV1 in Mesothelioma
https://www.globenewswire.com/news-release/2023/01/23/2592873/0/en/Ultimovacs-Announces-Completed-Patient-Recruitment-in-NIPU-Phase-II-Clinical-Trial-of-UV1-in-Mesothelioma.html
#BioStockSwe #lifescience @ultimovacs

Reply on Twitter 1617454314385211392 Retweet on Twitter 1617454314385211392 Like on Twitter 1617454314385211392 2 Twitter 1617454314385211392
biostock_news BioStock News @biostock_news ·
13 Dec

Mendus presents proof-of-concept data in AML maintenance
https://www.biostock.se/en/2022/12/mendus-presenterar-proof-of-concept-data-for-underhall-av-aml/
#BioStockSwe #lifescience @mendus_ab

Reply on Twitter 1602577051072045056 Retweet on Twitter 1602577051072045056 Like on Twitter 1602577051072045056 Twitter 1602577051072045056
biostock_news BioStock News @biostock_news ·
13 Dec

The innovative force behind Ultimovacs' cancer vaccine
https://www.biostock.se/en/2022/12/den-innovativa-kraften-bakom-ultimovacs-cancervaccin/
#BioStockSwe #lifescience @ultimovacs

Reply on Twitter 1602576486569050113 Retweet on Twitter 1602576486569050113 Like on Twitter 1602576486569050113 4 Twitter 1602576486569050113
Ladda fler
BioStock

BioStock is the leading digital news and analytics service in the Nordics, focusing exclusively on the life science sector.

OFFICE

Lund
Medicon Village, The Spark
Scheeletorget 1
223 81 Lund

Stockholm
Kungsgatan 33
111 56 Stockholm

BIOSTOCK

About BioStock
Career
Contact us

Cookie settings
© BioStock 2023


We need your consent

BioStock.se uses cookies to give you the most relevant experience by remembering your preferences, analyzing website usage and assisting us in our marketing efforts.

By clicking "Accept" you agree to the use of ALL cookies. You can also click on "Cookie settings" to customize your consent.

Cookie settings Accept Read More
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Functional
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Advertisement
Others
Save & Accept
Powered by CookieYes Logo